AIMM Therapeutics Presents Preclinical Data on its Four Oncology Therapies at AACR’s Annual Meeting Session on Antibody Technologies

Ads

You May Also Like

G1 Therapeutics to Provide Second Quarter 2018 Corporate and Financial Update on August 8, 2018

RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), ...

Oncothyreon Presents Phase 1b Results of ONT-380 in Combination with T-DM1 in HER2+ Metastatic Breast Cancer at ASCO

CHICAGO, June 05, 2016 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (NASDAQ:ONTY), a clinical-stage biopharmaceutical company, ...

CytomX and AbbVie Announce Strategic Collaboration for Probody Drug Conjugates

-  Companies to Jointly Develop and Commercialize Probody Drug Conjugates Directed Against CD71 -  ...